📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: AOP Orphan Pharmaceuticals

1.1 - Company Overview

AOP Orphan Pharmaceuticals Logo

AOP Orphan Pharmaceuticals

Headquarter: Austria
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of medicines for orphan indications and complex diseases, engaging in their development, marketing, and distribution.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to AOP Orphan Pharmaceuticals

MBX Biosciences Logo

MBX Biosciences

HQ: United States Website
  • Description: Provider of preclinical-stage biotech therapies for rare endocrine diseases, developing investigational candidates including MBX 2109 for consistent parathyroid hormone exposure in hypoparathyroidism, MBX 1416 to prevent severe hypoglycemia in post-bariatric hypoglycemia, MBX 4291, a long-acting GLP-1/GIP receptor co-agonist for obesity, and the PEP Platform for precision endocrine peptide therapeutics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MBX Biosciences company profile →
Brabant Pharma Logo

Brabant Pharma

HQ: Vietnam Website
  • Description: Provider of a late-stage oral treatment, Brabafen, under development for children with Dravet Syndrome (severe myoclonic epilepsy of infancy), a rare childhood epilepsy associated with catastrophic seizures resulting in mental and cognitive impairment.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Brabant Pharma company profile →
Design Therapeutics Logo

Design Therapeutics

HQ: United States Website
  • Description: Provider of GeneTAC small-molecule therapies that modulate gene expression to treat genetic diseases caused by nucleotide repeat expansions. Programs include Friedreich ataxia (DT-216, DT-216P2 to restore FXN), Fuchs endothelial corneal dystrophy (DT-168 eye drop), Huntington's disease (reduce mutant HTT), myotonic dystrophy DM1, and research for additional genetic diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Design Therapeutics company profile →
Palvella Therapeutics Logo

Palvella Therapeutics

HQ: United States Website
  • Description: Provider of therapies for abandoned patient populations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Palvella Therapeutics company profile →
SyntnX Logo

SyntnX

HQ: United States Website
  • Description: Provider of needle-free drug delivery solutions, discovering and developing novel, long-acting therapeutic products using proprietary Fc-fusion proteins and other engineered ligands that bind to specific Fc receptors. Technologies include the Transceptor drug delivery platform, harnessing the body's natural pathways.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SyntnX company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for AOP Orphan Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to AOP Orphan Pharmaceuticals

2.2 - Growth funds investing in similar companies to AOP Orphan Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for AOP Orphan Pharmaceuticals

4.2 - Public trading comparable groups for AOP Orphan Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to AOP Orphan Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About AOP Orphan Pharmaceuticals

What does AOP Orphan Pharmaceuticals do?

AOP Orphan Pharmaceuticals is a provider of medicines for orphan indications and complex diseases, engaging in their development, marketing, and distribution.

Who are AOP Orphan Pharmaceuticals's competitors?

AOP Orphan Pharmaceuticals's competitors and similar companies include MBX Biosciences, Brabant Pharma, Design Therapeutics, Palvella Therapeutics, and SyntnX.

Where is AOP Orphan Pharmaceuticals headquartered?

AOP Orphan Pharmaceuticals is headquartered in Austria.

How many employees does AOP Orphan Pharmaceuticals have?

AOP Orphan Pharmaceuticals has 1,000 employees 🔒.

When was AOP Orphan Pharmaceuticals founded?

AOP Orphan Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is AOP Orphan Pharmaceuticals in?

AOP Orphan Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for AOP Orphan Pharmaceuticals

Who are the top strategic acquirers in AOP Orphan Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in AOP Orphan Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for AOP Orphan Pharmaceuticals?

Top strategic M&A buyers groups and sectors for AOP Orphan Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in AOP Orphan Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in AOP Orphan Pharmaceuticals's sector and industry vertical?

Top PE firms investing in AOP Orphan Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in AOP Orphan Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in AOP Orphan Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in AOP Orphan Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to AOP Orphan Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in AOP Orphan Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for AOP Orphan Pharmaceuticals?

The key public trading comparables and valuation benchmarks for AOP Orphan Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for AOP Orphan Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for AOP Orphan Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in AOP Orphan Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for AOP Orphan Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in AOP Orphan Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in AOP Orphan Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for AOP Orphan Pharmaceuticals